Covid-19 patients

Less than Half Per Cent Among 65,000 Users of Ayurvedic Medicines Hospitalised During COVID Pandemic: AYUSH Secretary

PANAJI:Less than half per cent of around 65,000 COVID-19 patients, who used Ayurvedic formulations, were hospitalised and none of them…

1 year ago

Equipping Hospitals with COVID-19 Preparedness

NEW DELHI:Aimed towards strengthening the preparedness of charitable and government hospitals and COVID care centres in effectively responding to the…

3 years ago

YES BANK Enables Reward Points Redemption to Refill Oxygen Cylinders

MUMBAI:Reinforcing its commitment to support communities, YES BANK has enabled its customers to use their banking and credit card reward…

3 years ago

Infectiousness Peaks Earlier in COVID-19 Patients than Thought, Study Says

LONDON:People infected with the SARS-CoV-2 virus, that causes COVID-19, are most likely to be highly infectious in the first week…

3 years ago

Researchers Identify New Drug to Treat COVID-19 Patients

LONDON:In the continuing fight against the novel coronavirus, researchers have now identified a drug with the potential to provide treatment…

4 years ago

Glenmark Introduces NINDANIB (Nintedanib) at an Affordable Cost

KOCHI:Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment…

4 years ago

PNB Vesper Obtains Permission to Test its New Chemical Entity PNB 001 in COVID-19 Patients

KOCHI:PNB Vesper life science Pvt Ltd, is a leading Indian Pharma Research company with a vision to “work towards a…

4 years ago

1,897 New Corona Cases in Telangana

HYDERABAD: In one of the highest daily jumps in coronavirus infections, Telangana reported 1,897 new cases that increased its total…

4 years ago

Pankajakasthuri Clinical Trials of ZingiVir-H for COVID-19 Patients

THIRUVANANTHAPURAM: With the number of people infected by COVID-19 just under 2 million in India, Pankajakasthuri Herbals India Private Limited…

4 years ago

BDR Receives DCGI Approval for Favipiravir to Treat COVID-19

MUMBAI: BDR Pharmaceuticals –today announced the launch of Favipiravir for the treatment of COVID-19 patients in India. BDR Pharma has…

4 years ago

This website uses cookies.